Healthcare
•3753 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3753)
| Company | Market Cap | Price |
|---|---|---|
|
GOVX
GeoVax Labs, Inc.
GeoVax directly develops and manufactures vaccines using its MVA platform for infectious diseases (Mpox/smallpox and COVID-19 programs).
|
$3.03M |
$2.97
+4.21%
|
|
BZYR
Burzynski Research Institute, Inc.
Company focuses on oncology therapeutics in biotech R&D.
|
$3.02M |
$0.04
|
|
HCWB
HCW Biologics Inc.
HCWB's lead programs target oncology through novel immunotherapies, aligning with Biotech - Oncology.
|
$2.97M |
$1.36
+19.30%
|
|
CRVW
CareView Communications, Inc.
CareView's core offering is patient monitoring via video-based systems, including SitterView and TeleMedView components.
|
$2.96M |
$0.02
|
|
SOBR
SOBR Safe, Inc.
SOBR directly manufactures biometric-enabled medical devices (SOBRcheck) and wearable monitoring hardware (SOBRsure) paired with a cloud software platform.
|
$2.91M |
$1.91
+1.87%
|
|
BTCY
Biotricity, Inc.
Core cardiology device portfolio including 3-channel ECG monitoring platforms (Bioflux/Biocore/Biocore Pro).
|
$2.75M |
$0.30
|
|
MYNZ
Mainz Biomed B.V.
PancAlert is a blood-based diagnostic test using biomarker panels (liquid biopsy) to detect pancreatic cancer, fitting the Liquid Biopsy investable theme.
|
$2.69M |
$1.17
-2.10%
|
|
BICX
BioCorRx Inc.
BioCorRx is actively commercializing Lucemyra, an FDA-approved oral small molecule therapeutic for opioid withdrawal, expanding direct product sales.
|
$2.65M |
$0.40
|
|
ZYXI
Zynex, Inc.
Directly manufactures medical devices and biometrics used for patient monitoring and non-opioid pain management.
|
$2.64M |
$0.13
+83.21%
|
|
JAGX
Jaguar Health, Inc.
Jaguar Health focuses on crofelemer-based therapies delivered orally, aligning with the Oral Small Molecule Therapeutics category.
|
$2.54M |
$1.18
+3.98%
|
|
VTAK
Catheter Precision, Inc.
VTAK's VIVO System is a cardiology-focused medical device for non-invasive 3D mapping, aligning with Cardiology Devices.
|
$2.43M |
$2.15
-3.15%
|
|
MHUA
Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies' core business is the manufacturing and sale of disposable medical device consumables.
|
$2.43M |
$7.62
+0.13%
|
|
STSS
Sharps Technology, Inc.
Core product category: Safety syringes (SafeGard/Sologard) with passive safety features.
|
$2.43M |
$2.33
+1.30%
|
|
CARM
Carisma Therapeutics, Inc.
CAR-Macrophage platform is a cell-therapy technology, directly representing Carisma's core product category.
|
$2.33M |
$0.15
+196.92%
|
|
XWEL
XWELL, Inc.
XWEL's XpresTest program represents laboratory testing and advisory services, anchored by CDC collaborations and pathogen surveillance.
|
$2.27M |
$0.41
-2.61%
|
|
CLSD
Clearside Biomedical, Inc.
Clearside's core offering is a drug delivery platform enabling suprachoroidal (eye) delivery and extended-release formulations.
|
$2.15M |
$0.43
+4.90%
|
|
AAGH
America Great Health
Joint venture and activities in cell therapy and regenerative medicine.
|
$2.12M |
$0.00
|
|
YBGJ
Yubo International Biotech Limited
Endometrial stem cell research and potential cell therapies (core biotech focus).
|
$2.11M |
$0.01
|
|
CANF
Can-Fite BioPharma Ltd.
Company focuses on orally bioavailable small molecule therapeutics targeting A3AR, including Piclidenoson and Namodenoson.
|
$1.99M |
$4.00
-6.54%
|
|
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Company is a oncology-focused biotech developing radiation sensitizers and HDAC inhibitor therapeutics, with lead assets in Phase 2/preclinical stages.
|
$1.98M |
$1.79
-2.97%
|
|
BIOE
Bio Essence Corporation
Provides outsourced contract manufacturing (OEM) services for health-related products.
|
$1.94M |
$0.05
|
|
APVO
Aptevo Therapeutics Inc.
APVO is a oncology-focused biotech developing novel immunotherapies, including mipletamig and other pipelines targeting cancer.
|
$1.73M |
$9.35
+3.49%
|
|
ELAB
PMGC Holdings Inc.
Contract Research Organizations (CRO)-like R&D capabilities through PMGC Research Inc. for biotech development.
|
$1.63M |
$3.35
-13.12%
|
|
REVB
Revelation Biosciences, Inc.
Core product focus on modulating innate immunity using the Gemini platform, aligning with Immunology Therapeutics.
|
$1.61M |
$0.95
+6.12%
|
|
ENVB
Enveric Biosciences, Inc.
Enveric is focused on neuropsychiatric drug development with a lead program targeting neuroplasticity-based therapies.
|
$1.45M |
$5.21
-2.71%
|
|
SXTC
China SXT Pharmaceuticals, Inc.
SXTC manufactures TCMP products and operates GMP-compliant production lines, consistent with a contract manufacturing organization (CMO) model.
|
$1.31M |
$0.09
-11.59%
|
|
GRTX
Galera Therapeutics, Inc.
Company directly develops oncology therapeutics, including its NOS pan-inhibitor and SOD mimetics for cancer indications.
|
$1.31M |
$0.02
|
|
BIAF
bioAffinity Technologies, Inc.
CyPath Lung testing is delivered as a laboratory testing service via Precision Pathology Laboratory Services (PPLS).
|
$1.30M |
$1.35
-4.93%
|
|
VYST
Vystar Corporation
Replacement cartridges for RxAir units represent consumable medical device components with recurring revenue.
|
$1.26M |
$0.06
|
Showing page 37 of 38 (3753 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
